UMC IDMP Request and Publish API, published by Uppsala Monitoring Centre. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/Uppsala-Monitoring-Centre/WHO-UMC-IDMP-Service/ and changes regularly. See the Directory of published versions
{
"resourceType" : "MedicinalProductDefinition",
"id" : "1A0661AE2A40",
"meta" : {
"versionId" : "1",
"lastUpdated" : "2018-02-24T08:23:55.3332666+00:00",
"source" : "https://poc-idmp.who-umc.org/fhir",
"profile" : [
🔗 "http://who-umc.org/idmp/StructureDefinition/MedicinalProductDefinition-who-php-pub"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\" style=\"font-family: Helvetica;\"><h1 style=\"color: darkblue; background: lightgray; padding: 5px;\">Medicinal Product (Medicinal Product Definition)</h1><table style=\"padding: 5px; text-align: left;\"><tr><td style=\"font-weight: bold;\">Id</td><td>1A0661AE2A40</td></tr><tr><td style=\"font-weight: bold;\">Name</td><td>Auro methotrexate</td></tr><tr><td style=\"font-weight: bold;\">Mah</td><td>Auro Pharma Inc</td></tr><tr><td style=\"font-weight: bold;\">Jurisdiction</td><td>Canada</td></tr></table><h2 style=\"color: darkblue; background: lightgray; padding: 5px;\">ATC</h2><table style=\"padding: 5px; text-align: left;\"><th>Code</th><th>Display</th><tr><td>G02CX</td><td>Other gynecologicals</td></tr><tr><td>L01BA</td><td>Folic acid analogues</td></tr><tr><td>L04AX</td><td>Other immunosuppressants</td></tr></table><h2 style=\"color: darkblue; background: lightgray; padding: 5px;\">Codes</h2><table style=\"padding: 5px; text-align: left;\"><th>System</th><th>Code</th><th>Display</th><tr><td>http://who-umc.org/idmp/CodeSystem/drugcode</td><td>00113802216</td><td/></tr></table><h2 style=\"color: darkblue; background: lightgray; padding: 5px;\">PhPIDs</h2><table style=\"padding: 5px; text-align: left;\"><th>Level</th><th>Code</th><tr><td>4</td><td>91B3CA582581F57E4092F13AAF476215</td></tr></table></div>"
},
"contained" : [
{
"resourceType" : "Organization",
"id" : "auropharmainc",
"name" : "Auro Pharma Inc"
},
{
"resourceType" : "RegulatedAuthorization",
"id" : "regauth",
"subject" : [
{
"reference" : "#"
}
],
"holder" : {
"reference" : "#auropharmainc"
}
}
],
"identifier" : [
{
"system" : "https://gupri-idmp.who-umc.org/data/record",
"value" : "1A0661AE2A40"
},
{
"system" : "https://health-products.canada.ca/dpd-bdpp",
"value" : "02182750"
}
],
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/medicinal-product-type",
"code" : "MedicinalProduct"
}
]
},
"domain" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/medicinal-product-domain",
"code" : "Human"
}
],
"text" : "Human use"
},
"status" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active"
}
],
"text" : "Active"
},
"combinedPharmaceuticalDoseForm" : {
"text" : "TABLETS"
},
"classification" : [
{
"coding" : [
{
"system" : "http://who-umc.org/idmp/level4-phpid",
"code" : "91B3CA582581F57E4092F13AAF476215"
}
]
},
{
"coding" : [
{
"system" : "http://www.whocc.no/atc",
"code" : "G02CX"
}
],
"text" : "Other gynecologicals"
},
{
"coding" : [
{
"system" : "http://www.whocc.no/atc",
"code" : "L01BA"
}
],
"text" : "Folic acid analogues"
},
{
"coding" : [
{
"system" : "http://www.whocc.no/atc",
"code" : "L04AX"
}
],
"text" : "Other immunosuppressants"
}
],
"code" : [
{
"system" : "http://who-umc.org/idmp/CodeSystem/drugcode",
"code" : "00113802216"
}
],
"name" : [
{
"productName" : "Auro methotrexate",
"usage" : [
{
"country" : {
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "CAN"
}
]
},
"jurisdiction" : {
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "CAN"
}
]
},
"language" : {
"coding" : [
{
"system" : "urn:ietf:bcp:47",
"code" : "en"
}
]
}
}
]
}
]
}